(29 days)
1212FCA
0909FCC, 0909FCC-HS
No
The summary describes a digital X-ray detector and associated software for image processing and conversion to DICOM format. There is no mention of AI, ML, or any advanced analytical capabilities beyond basic image processing for display and storage. The performance studies focus on standard imaging metrics (MTF, DQE, NPS) and comparison to a predicate device, not on AI/ML performance metrics.
No
The device is an X-ray detector used for capturing and digitalizing X-ray images for radiographic diagnosis and analysis, not for treatment.
Yes
The 'Intended Use / Indications for Use' section states that the device is "intended to replace the x-ray imager on film based radiographic diagnostic systems." Additionally, the 'Device Description' mentions that the device "can be utilized to capture and digitalize X-ray images for radiographic diagnosis." These statements clearly indicate its role in diagnostic processes.
No
The device description explicitly states it is a "digital solid state X-ray detectors based on flat-panel technology" and includes physical components like a scintillator and TFT sensor, connected via wired LAN. While it includes software for processing, it is fundamentally a hardware device for capturing X-ray images.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening.
- Device Function: The description clearly states that this device is an X-ray detector designed to capture and digitalize X-ray images of the human body (head, neck, limbs, etc.). It works by detecting X-rays that have passed through the patient.
- No Specimen Analysis: The device does not analyze any biological specimens taken from the patient. It directly interacts with the patient's body via X-rays.
Therefore, this device falls under the category of a radiological imaging device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
"0909FCC and 0909FCC-HS are indicated for digital imaging solution designed including head, neck, cervical spine, arm, leg and peripheral (foot, hand, wrist, fingers, etc.). The detectors are intended to replace the x-ray imager on film based radiographic diagnostic systems. Not to be used for mammography."
Product codes
MQB, JAA
Device Description
0909FCC and 0909FCC-HS are digital solid state X-ray detectors based on flat-panel technology. This radiographic image detector and processing unit consists of a scintillator coupled to Indium Ginc Oxide (IGZO) on TFT sensor. This device is connected to the user PC via wired LAN (ethernet cable) and it needs to be integrated with a radiographic imaging system. It does not operate as an X-ray generator controller but can be utilized to capture and digitalize X-ray images for radiographic diagnosis. The RAW files can be further processed as DICOM compatible image files by separate console SW(Xmaru RF Lite) for a radiographic diagnosis and analysis. 0909FCC is a basic model. 0909FCC-HS is identical with a basic model except for marking of sheet not related to safety. 0909 FCC and 0909 FCC-HS are intended to capture dynamic images. The Xmaru RF lite imaging software is included in the system but the computer that receives the digital images is not provided with the system.
0909FCC and 0909FCC-HS are compatible with the X-ray generator, HTC-35B by Poskom Co.,Ltd, which is not provided with the system.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray
Anatomical Site
head, neck, cervical spine, arm, leg and peripheral (foot, hand, wrist, fingers, etc.)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The non-clinical test report for the subject device was prepared and submitted to FDA to demonstrate the substantial equivalency of the subject device performance compared to the predicate device. The results of bench testing indicate substantial equivalence of the subject detectors 0909FCC, 0909FCC-HS and the predicate device. The non-clinical test report contains the MTF, DQE and NPS performance test comparison between the subject device (0909FCC), and the predicate device (1212FCA), by using the identical test equipment and same analysis method described by IEC 62220-1. The MTF and DQE testing represent the ability to visualize object details of a certain size and contrast. 0909FCC demonstrated equivalent or better performance in terms of MTF and DQE compared to 1212FCA, the predicate device, at all spatial frequencies.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
MTF, DQE, NPS
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1680 Stationary x-ray system.
(a)
Identification. A stationary x-ray system is a permanently installed diagnostic system intended to generate and control x-rays for examination of various anatomical regions. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A radiographic contrast tray or radiology diagnostic kit intended for use with a stationary x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the text "U.S. Food & Drug Administration" in blue.
March 7, 2024
Rayence Co., Ltd % Mr. Dave Kim Medical Device Regulatory Consultant Mtech Group LLC 7505 Fannin St. Ste 610 HOUSTON, TX 77054
Re: K240371
Trade/Device Name: 0909FCC, 0909FCC-HS Regulation Number: 21 CFR 892.1680 Regulation Name: Stationary x-ray system Regulatory Class: Class II Product Code: MQB, JAA Dated: January 19, 2024 Received: February 7, 2024
Dear Mr. Dave Kim:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
1
Your device is also subject to, among other requirements, the Quality System (OS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Page
2
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Lu Jiang
Lu Jiang, Ph.D. Assistant Director Diagnostic X-Ray Systems Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
2
Indications for Use
510(k) Number (if known) K240371
Device Name 0909FCC, 0909FCC-HS
Indications for Use (Describe)
"0909FCC and 0909FCC-HS are indicated for digital imaging solution designed including head, neck, cervical spine, arm, leg and peripheral (foot, hand, wrist, fingers, etc.). The detectors are intended to replace the x-ray imager on film based radiographic diagnostic systems. Not to be used for mammography."
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary (K240371)
This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of 21 CFR Part 807.92.
- Date 510k summary prepared: January 19,2024
-
- Submitter's Name, address, telephone number, a contact person:
| Submitter's Name : | Rayence Co., Ltd. |
|---|---|
| Submitter's Address: | 14, Samsung 1-ro 1-gil, Hwaseong-si, Gyeonggi-do, Korea |
| Submitter's Telephone: | +82-31-8015-6459 |
| Contact person: | Mr. Inhwan Bang / QMR / +82-31-8015-6427 |
| Official Correspondent: | Mr. Dave Kim, MBA (davekim@mtechgroupllc.com) |
| Mtech Group LLC | |
| Address: | 7505 Fannin St. 610, Houston, TX 77054 |
| Telephone: | +1-713-467-2607 |
Name of the device, including the trade or proprietary name if applicable, the common or usual name and the classification name, if known:
| 3. Trade/proprietary name | : 0909FCC, 0909FCC-HS |
|---|---|
| Common Name | : Digital Flat Panel X-ray Detector |
| Regulation Number | : 21 CFR 892.1680 |
| Regulation Name | : Stationary X-ray System |
| Regulatory Class | : Class II |
| Product Code | : MQB, JAA |
4. Primary Predicate Device :
| Trade/Device Name | :1212FCA |
|---|---|
| Common Name | : Digital Flat Panel X-ray Detector |
| 510(k) Number | : K212753 |
| Regulation Number | : 21 CFR 892.1680 |
| Regulation Name | : Stationary X-ray System |
4
| Regulatory Class | : Class II |
|---|---|
| Product Code | : MQB, JAA |
5. Device Description
0909FCC and 0909FCC-HS are digital solid state X-ray detectors based on flat-panel technology. This radiographic image detector and processing unit consists of a scintillator coupled to Indium Ginc Oxide (IGZO) on TFT sensor. This device is connected to the user PC via wired LAN (ethernet cable) and it needs to be integrated with a radiographic imaging system. It does not operate as an X-ray generator controller but can be utilized to capture and digitalize X-ray images for radiographic diagnosis. The RAW files can be further processed as DICOM compatible image files by separate console SW(Xmaru RF Lite) for a radiographic diagnosis and analysis. 0909FCC is a basic model. 0909FCC-HS is identical with a basic model except for marking of sheet not related to safety. 0909 FCC and 0909 FCC-HS are intended to capture dynamic images. The Xmaru RF lite imaging software is included in the system but the computer that receives the digital images is not provided with the system.
0909FCC and 0909FCC-HS are compatible with the X-ray generator, HTC-35B by Poskom Co.,Ltd, which is not provided with the system.
6. Indication for use
0909FCC and 0909FCC-HS are indicated for digital imaging solution designed including head, neck, cervical spine, arm, leg and peripheral (foot, hand, wrist, fingers, etc.). The detectors are intended to replace the x-ray imager on film based radiographic diagnostic systems. Not to be used for mammography.
7. Summary of Design Control Risk management
0909FCC and 0909FCC-HS digital X-ray detectors are modifications of the 1212FCA (K212753). 0909FCC and 0909FCC-HS were developed for the purpose of retrofitting the stationary X-ray system with a film detector. 0909FCC and 0909FCC-HS are slightly smaller than 1212FCA (K212753). The risks and the hazardous impact of the device modification were analyzed with FMEA method. The specific risk control and protective measures to mitigate the risks from the modification were reviewed and implemented in the new product design phase. The overall assessment concluded that all risks and
5
hazardous conditions identified arising from the design change were successfully mitigated and accepted.
8. Summary of the technological characteristics of the device compared to the predicate device:
0909FCC and 0909FCC-HS detectors described in this 510(k) have the same indications for use and similar technical characteristics as its predicate devices, 1212FCA(K212753).
8.1 Scintillator layer
*scintillator layer. ( * scintillator : a phosphor that produces scintillations)
| Proposed | Predicate | |
|---|---|---|
| CsI (Cesium Iodide) | 0909FCC, 0909FCC-HS | 1212FCA |
8.2. Power source : ATM065T-P240 or AHM85PS24
| | | Proposed
0909FCC, 0909FCC-HS | Predicate
1212FCA |
|-------|------------|--------------------------------------------------------------------|------------------------------------------------------------------|
| Power | Type | Power adapter | Power adapter |
| | Model name | AHM85PS24 | AHM85PS24 |
| | Dimension | 150 X 64 X 37
(cable length: 900 mm) | 150 X 64 X 37
(cable length: 900 mm) |
| | Weight | 0.4kg | 0.4kg |
| | Rating | Input: 100-240 Vac, 1.0 A, 50/60 Hz
Output: Typ. 24 VDC, 3.54 A | Input: 100-240 Vac, 1.0 A, 50/60 Hz
Output: 24VDC (Max 3.54A) |
| | | Proposed
0909FCC, 0909FCC-HS | Predicate
1212FCA |
|-------|------------|--------------------------------------------------------------------|------------------------------------------------------------------|
| Power | Type | Power adapter | Power adapter |
| | Model name | ATM065T-P240 | AHM85PS24 |
| | Dimension | 119 X 60 X 36 (cable length: 1500
mm) | 150 X 64 X 37
(cable length: 900 mm) |
| | Weight | 0.31kg | 0.4kg |
| | Rating | Input: 100-240 Vac, 1.6 A, 50/60 Hz
Output: Typ. 24 VDC, 2.71 A | Input: 100-240 Vac, 1.0 A, 50/60 Hz
Output: 24VDC (Max 3.54A) |
6
Image /page/6/Picture/0 description: The image contains the word "rayence" in lowercase letters. The word is written in a red, sans-serif font. The background of the image is white.
| Characteristic | Proposed Device | Predicate Device | Similarity |
|---|---|---|---|
| Manufacturer | Rayence Co.,Ltd. | Rayence Co.,Ltd. | |
| 510k No: | K240371 | K212753 | |
| Product Name | 0909FCC | ||
| 0909FCC-HS | 1212FCA | ||
| Feature | Image: 0909FCC and 0909FCC-HS | Image: 1212FCA | |
| 510(k) number | K212753 | Same | |
| Indications for | |||
| Use | 0909FCC and 0909FCC-HS are indicated for | ||
| digital imaging solution designed including | |||
| head, neck, cervical spine, arm, leg and | |||
| peripheral (foot, hand, wrist, fingers, etc.). The | |||
| detectors are intended to replace the x-ray | |||
| imager on film based radiographic diagnostic | |||
| systems. Not to be used for mammography. | 1212FCA is indicated | ||
| for digital imaging | |||
| solution designed for | |||
| human anatomy | |||
| including head, neck, | |||
| cervical spine, arm, leg | |||
| and peripheral (foot, | |||
| hand, wrist, fingers, | |||
| etc.). It is intended to | |||
| replace film based | |||
| radiographic diagnostic | |||
| systems and provide a | |||
| case diagnosis and | |||
| treatment planning for | |||
| physicians and other | |||
| health care | |||
| professionals. Not to be | |||
| used for mammography. | Same | ||
| Detector Type | IGZO TFT + PIN type photodiode | IGZO TFT + PIN type | |
| photodiode | Same | ||
| Scintillator | CsI:Tl | CsI:Tl | Same |
| Imaging Area | 9 x 9 inches | 12 x 12 inches | Similar |
| Effective Pixel | |||
| matrix | 1464 X 1464 (1x1 Full resolution) | ||
| 732 X 732 (2x2 binning) | 1500 X 1500 (1x1) | ||
| 750 X 750 (2x2) | Same | ||
| Pixel pitch | 140 µm (Full resolution) | ||
| 280 µm (2x2 binning) | 194 µm (1x1) | ||
| 388 µm (2x2) | Similar | ||
| A/D | |||
| conversion | 14/16 bits | 14 / 16 bit | Same |
| Frame rate | 5GigE 29 @ (1x1) | ||
| 58 @ (2x2) | GigE 18 (1x1) | ||
| 36 (2x2) | Similar | ||
| Max. | |||
| resolution | |||
| (lp/mm) | 3.57 lp/mm (full resolution ) | ||
| 1.79 lp/mm (2x2 binning) | 2.58 lp/mm (full resol.) | ||
| 1.29 lp/mm (2x2) | Similar | ||
| lp/mm) | |||
| DQE (0.5) | 0.789 | 0.753 | Similar |
| Data output | RAW | ||
| *The RAW files are convertible into DICOM 3.0 by | |||
| console S/W | RAW | ||
| *The RAW files are | |||
| convertible into DICOM | |||
| 3.0 by console S/W | Same | ||
| Dimensions | 280.0 X 280.0 X 45.0mm | 334.0 x 326.0 x 49.9 mm | Similar |
| Weight | 2.8 kg | 3.4 kg | Similar |
| Imaging | |||
| Software | XmaruRF Lite (provided with 0909FCC and | ||
| 0909FCC-HS) | - | - |
8.3 Comparison with Predicate Device
7
Image /page/7/Picture/0 description: The image shows the word "rayence" in red font. The font is sans-serif and appears to be bolded. The background is white.
9. Summary of Performance Testing
0909FCC and 0909FCC-HS Digital Flat Panel X-Ray Detectors have the same indications for use, the same scintillator material (Csl:T1 ) coupled to Indium Zinc Oxide (IGZO) on TFT sensor, the same generator specifications and the same risk analysis characteristics compared to 1212FCA, the predicate devices (K212753). The pixel matrix and pixel pitch sizes are different imaging areas but the differences do not raise new concerns for the safety and effectiveness of the subject device.
The non-clinical test report for the subject device was prepared and submitted to FDA to demonstrate the substantial equivalency of the subject device performance compared to the predicate device.
The results of bench testing indicate substantial equivalence of the subject detectors 0909FCC, 0909FCC-HS and the predicate device.
The non-clinical test report contains the MTF, DQE and NPS performance test comparison between the subject device (0909FCC), and the predicate device (1212FCA), by using the identical test equipment and same analysis method described by IEC 62220-1.
The MTF and DQE testing represent the ability to visualize object details of a certain size and contrast. 0909FCC demonstrated equivalent or better performance in terms of MTF and DQE compared to 1212FCA, the predicate device, at all spatial frequencies.
Based on non-clinical consideration evaluation, substantial equivalence between the subject device and predicate device in terms of diagnostic image quality has been demonstrated.
The manufacturing facility is in conformance with the design control procedure requirements specified in 21 CFR 820.30 and the relevant 21CFR820 standards as the records are available for review. Furthermore,
8
the device will conform with all labeling requirements as per 21 CFR Subchapter J.
10. Summary for any testing and reference guidance:
- A Electrical, mechanical, environmental safety and performance testing according to standard IEC 60601-1: 2020 (Medical electrical equipment Part 1:General requirements for basic safety and essential performance)
- A EMC testing were conducted in accordance with standard IEC 60601-1-2: 2020
- A IEC 62220-1 Ed 1.0 Medical electrical equipment-Characteristics of digital X-ray imaging devices Part 1-1: Determination of the detective quantum efficiency Detectors used in radiographic imaging
- A Non-clinical consideration according to FDA Guidance "Guidance for the Submissions of 510(k)'s for Solid State X-ray Imaging Devices"
-
"Guidance for the Contents of Premarket Submission for Software Contained in Medical Device".
- A Pediatric Information for X-ray Imaging Device Premarket Notifications
- Content of Premarket Submissions for Management of Cybersecurity in Medical Devices A
11. Conclusions:
In accordance with the performance outcomes, 0909FCC and 0909FCC-HS demonstrated equivalent or better performance compared to 1212FCA(K212753). Therefore, Rayence claims that based on non-clinical consideration evaluation, substantial equivalence between the subject device and predicate device in terms of diagnostic image quality has been demonstrated.